Quipt Home Medical Corp. provides in-home monitoring equipment and disease management services includes end-to-end respiratory solutions for patients in the United States. It offers daily and ambulatory aides; power mobility equipment; BiPAP and CPAP machines, nebulizers, oxygen concentrators, and ventilators; oxygen therapy; sleep apnea and PAP treatment equipment; and home ventilator equipment, as well as rents respiratory equipment. The company also offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. was incorporated in 1993 and is headquartered in Wilder, Kentucky.
IPO Year:
Exchange: NASDAQ
Website: quipthomemedical.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/17/2024 | Mkt Perform → Underperform | Raymond James | |
| 2/16/2024 | Outperform → Mkt Perform | Raymond James | |
| 6/14/2023 | $11.00 | Buy | Canaccord Genuity |
| 10/20/2021 | $7.50 | Buy | The Benchmark Company |
| 10/20/2021 | $7.50 | Buy | Benchmark |
4 - Quipt Home Medical Corp. (0001540013) (Issuer)
SC 13D - Quipt Home Medical Corp. (0001540013) (Subject)
SC 13G/A - Quipt Home Medical Corp. (0001540013) (Subject)
SC 13G - Quipt Home Medical Corp. (0001540013) (Subject)
SC 13G/A - Quipt Home Medical Corp. (0001540013) (Subject)
SC 13G - Quipt Home Medical Corp. (0001540013) (Subject)
SC 13G/A - Quipt Home Medical Corp. (0001540013) (Subject)
SC 13G - Quipt Home Medical Corp. (0001540013) (Subject)
4 - Quipt Home Medical Corp. (0001540013) (Issuer)
3 - Quipt Home Medical Corp. (0001540013) (Issuer)
3 - Quipt Home Medical Corp. (0001540013) (Issuer)
3 - Quipt Home Medical Corp. (0001540013) (Issuer)
3 - Quipt Home Medical Corp. (0001540013) (Issuer)
3 - Quipt Home Medical Corp. (0001540013) (Issuer)
3 - Quipt Home Medical Corp. (0001540013) (Issuer)
3 - Quipt Home Medical Corp. (0001540013) (Issuer)
3 - Quipt Home Medical Corp. (0001540013) (Issuer)
3 - Quipt Home Medical Corp. (0001540013) (Issuer)
CINCINNATI, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its first quarter fiscal year 2025 financial results and operational highlights. These results pertain to the three months ended December 31, 2024 and are reported in U.S. Dollars. Conference Call Quipt will host its Earnings Conference Call on Tuesday, February 11, 2025 at 10:00 a.m. (ET). Interested parties may participate in the call by dialing 1 (844) 763-8274 or 1 (647) 484-8814. A live webcast of the call will be accessible via the Company's website at https:/
CINCINNATI, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal first quarter 2025 financial results on Monday, February 10, 2025, after market close. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Tuesday, February 11, 2025, at 10:00 a.m. (ET). The call-in numbers for participants are: Canada/US Toll Free:1 (844) 763 8274International: 1 (647) 484 8814 A live webcast of the call will be accessible via the investor section of the Com
Posts Strong Adjusted EBITDA Margin1 for Fiscal Year 2024 and Returns to Positive Sequential Growth in Fiscal Q4 2024 CINCINNATI, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its fourth quarter and fiscal year 2024 financial results and operational highlights. These results pertain to the three months and year ended September 30, 2024 and are reported in U.S. Dollars. The Company no longer qualifies as a "foreign private issuer" as such term is defined in Rule 405 under the U.S. Securities Act of 1933, as ame
CINCINNATI, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT) (TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal fourth quarter and full year 2024 financial results on Monday, December 16, 2024, after market close. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Tuesday, December 17, 2024, at 10:00 a.m. (ET). The call-in numbers for participants are: Canada/US Toll Free: 1 (844) 763 8274International: 1 (647) 484 8814 A live webcast of the call will be a
CINCINNATI, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S.-based home medical equipment provider, focused on end-to-end respiratory care, today announced its third quarter fiscal 2024 financial results and operational highlights. These results pertain to the three and nine months ended June 30, 2024, and are reported in United States dollars ("$", "dollars" and "US$") and have been rounded to the nearest hundred thousand. Quipt will host its Earnings Conference Call on Thursday, August 15, 2024, at 10:00 a.m. (ET). The dial-in number is 1 (844) 763 8274 or 1 (647) 484 8814. The live audio webcast can be found on the investor sect
CINCINNATI, July 31, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT) (TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal third quarter 2024 financial results on Wednesday, August 14, 2024, after market close. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Thursday, August 15, 2024, at 10:00 a.m. (ET). The call-in numbers for participants are: Canada/US Toll Free: 1 (844) 763 8274 International: 1 (647) 484 8814 A live webcast of the call will be accessible via the investor section of t
• Posts Adjusted EBITDA Margin of 23.3% as a % of Revenue • Announced Normal Course Issuer Bid ("NCIB") Subsequent to Quarter End CINCINNATI, May 15, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S.-based home medical equipment provider, focused on end-to-end respiratory care, today announced its second quarter fiscal 2024 financial results and operational highlights. These results pertain to the three and six months ended March 31, 2024, and are reported in United States dollars ("$", "dollars" and "US$") and have been rounded to the nearest hundred thousand. Quipt will host its Earnings Conference Call on Thursday, May 16, 2024, at 10:
CINCINNATI, May 06, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT) (TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal second quarter 2024 financial results on Wednesday, May 15, 2024. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Thursday, May 16, 2024, at 10:00 a.m. (ET). The call-in numbers for participants are: Canada/US Toll Free:1 (844) 763 8274 International:1 (647) 484 8814 A live webcast of the call will be accessible via the investor section of the Company's website through
CINCINNATI, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its first quarter fiscal 2024 financial results and operational highlights. These results pertain to the three months ended December 31, 2023, and are reported in United States dollars ("$", "dollars" and "US$") and have been rounded to the nearest hundred thousand. Quipt will host its Earnings Conference Call on Thursday, February 15, 2024, at 10:00 a.m. (ET). The dial-in number is 1 (800) 319-4610 or 1 (604) 638-5340. The live audio webcast can be found on the investor secti
CINCINNATI, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT) (TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal first quarter 2024 financial results on Wednesday, February 14, 2024. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Thursday, February 15, 2024, at 10:00 a.m. (ET). The call-in numbers for participants are: Canada/US Toll Free:1 (800) 319 4610International:1 (604) 638 5340 A live webcast of the call will be accessible via the investor section of the Company's website t
CINCINNATI, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its first quarter fiscal year 2025 financial results and operational highlights. These results pertain to the three months ended December 31, 2024 and are reported in U.S. Dollars. Conference Call Quipt will host its Earnings Conference Call on Tuesday, February 11, 2025 at 10:00 a.m. (ET). Interested parties may participate in the call by dialing 1 (844) 763-8274 or 1 (647) 484-8814. A live webcast of the call will be accessible via the Company's website at https:/
CINCINNATI, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT) (TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, acknowledges receipt of a notice from Philotimo Fund, LP, an entity affiliated with Kanen Wealth Management, LLC and David L. Kanen ("KWM"), purporting to provide notice of its intent to solicit proxies in support of four director candidates to the Company's Board of Directors (the "Board") in opposition to the Company's four director candidates to the Board. The Company remains steadfast in its mission to deliver long-term value to all shareholders. As part of the Company's ongoing commitment
CINCINNATI, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal first quarter 2025 financial results on Monday, February 10, 2025, after market close. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Tuesday, February 11, 2025, at 10:00 a.m. (ET). The call-in numbers for participants are: Canada/US Toll Free:1 (844) 763 8274International: 1 (647) 484 8814 A live webcast of the call will be accessible via the investor section of the Com
Posts Strong Adjusted EBITDA Margin1 for Fiscal Year 2024 and Returns to Positive Sequential Growth in Fiscal Q4 2024 CINCINNATI, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its fourth quarter and fiscal year 2024 financial results and operational highlights. These results pertain to the three months and year ended September 30, 2024 and are reported in U.S. Dollars. The Company no longer qualifies as a "foreign private issuer" as such term is defined in Rule 405 under the U.S. Securities Act of 1933, as ame
CINCINNATI, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT) (TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal fourth quarter and full year 2024 financial results on Monday, December 16, 2024, after market close. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Tuesday, December 17, 2024, at 10:00 a.m. (ET). The call-in numbers for participants are: Canada/US Toll Free: 1 (844) 763 8274International: 1 (647) 484 8814 A live webcast of the call will be a
CINCINNATI, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S.-based home medical equipment provider, focused on end-to-end respiratory care, today announced its third quarter fiscal 2024 financial results and operational highlights. These results pertain to the three and nine months ended June 30, 2024, and are reported in United States dollars ("$", "dollars" and "US$") and have been rounded to the nearest hundred thousand. Quipt will host its Earnings Conference Call on Thursday, August 15, 2024, at 10:00 a.m. (ET). The dial-in number is 1 (844) 763 8274 or 1 (647) 484 8814. The live audio webcast can be found on the investor sect
CINCINNATI, July 31, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT) (TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal third quarter 2024 financial results on Wednesday, August 14, 2024, after market close. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Thursday, August 15, 2024, at 10:00 a.m. (ET). The call-in numbers for participants are: Canada/US Toll Free: 1 (844) 763 8274 International: 1 (647) 484 8814 A live webcast of the call will be accessible via the investor section of t
• Posts Adjusted EBITDA Margin of 23.3% as a % of Revenue • Announced Normal Course Issuer Bid ("NCIB") Subsequent to Quarter End CINCINNATI, May 15, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S.-based home medical equipment provider, focused on end-to-end respiratory care, today announced its second quarter fiscal 2024 financial results and operational highlights. These results pertain to the three and six months ended March 31, 2024, and are reported in United States dollars ("$", "dollars" and "US$") and have been rounded to the nearest hundred thousand. Quipt will host its Earnings Conference Call on Thursday, May 16, 2024, at 10:
CINCINNATI, Ohio, May 09, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, has filed and obtained a receipt for its final short form base shelf prospectus (the "Final Shelf Prospectus") with the securities commissions in each of the provinces and territories of Canada, and a corresponding Amendment No. 2 to the Registration Statement on Form F-10 (File No. 333-276253) previously filed by the Company with the United States Securities and Exchange Commission (the "SEC") on December 22, 2023 (the "Amended Registration Statement"), with the SEC under the U.S./Canada
CINCINNATI, May 06, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT) (TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal second quarter 2024 financial results on Wednesday, May 15, 2024. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Thursday, May 16, 2024, at 10:00 a.m. (ET). The call-in numbers for participants are: Canada/US Toll Free:1 (844) 763 8274 International:1 (647) 484 8814 A live webcast of the call will be accessible via the investor section of the Company's website through
Raymond James downgraded Quipt Home Medical from Mkt Perform to Underperform
Raymond James downgraded Quipt Home Medical from Outperform to Mkt Perform
Canaccord Genuity resumed coverage of Quipt Home Medical with a rating of Buy and set a new price target of $11.00
The Benchmark Company initiated coverage of Quipt Home Medical with a rating of Buy and set a new price target of $7.50
Benchmark initiated coverage of Quipt Home Medical with a rating of Buy and set a new price target of $7.50
10-Q - Quipt Home Medical Corp. (0001540013) (Filer)
8-K - Quipt Home Medical Corp. (0001540013) (Filer)
8-K - Quipt Home Medical Corp. (0001540013) (Filer)
DEFA14A - Quipt Home Medical Corp. (0001540013) (Filer)
DEFA14A - Quipt Home Medical Corp. (0001540013) (Filer)
DEFA14A - Quipt Home Medical Corp. (0001540013) (Filer)
DEFA14A - Quipt Home Medical Corp. (0001540013) (Filer)
DEF 14A - Quipt Home Medical Corp. (0001540013) (Filer)
10-K - Quipt Home Medical Corp. (0001540013) (Filer)
8-K - Quipt Home Medical Corp. (0001540013) (Filer)
CINCINNATI, March 28, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT) (TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced the voting results from its annual general and special meeting of shareholders held on March 27, 2024 (the "Meeting") in Wilder, Kentucky. The total number of shares represented in person or by proxy at the Meeting was 25,432,699, representing 60.4% of the total issued and outstanding shares in the capital of the Company. Election of Directors The four candidates nominated for election to the Company's Board of Directors (the "Board") and listed in the Company's manageme
CINCINNATI, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, announced today that Mr. Brian J. Wessel has joined the Board of Directors of the Company as an Independent Director and Chair of the Audit Committee. Mr. Wessel is a senior business executive with over 34 years of global client service, operational and financial expertise. As a former senior partner at Ernst & Young ("EY"), Mr. Wessel provided audit and advisory services to public, private, and private-equity-owned companies across multiple industry sectors. Additio